A young girl with a five year history of seropositive rheumatoid arthritis developed acute profound anaemia. Hypothyroidism was diagnosed and the anaemia remitted upon correction of the hypothyroid state. Although hypothyroidism is known to cause an anaemia, the mechanism is unclear and we believe that this is the first report of rheumatoid arthritis and profound anaemia which cannot clearly be attributed to drugs.
Case report
A 13-year-old girl presented in July 1979 with swollen, painful knees, ankles and wrists. Investigations showed a normal full blood picture. Rheumatoid factor titre was positive (Rose-Waaler DAT 1164 and X-rays confirmed erosive disease. Thyroid function tests were normal (free thyroxine index 66, normal range 55-150, thyroid stimulating hormone 6, normal range 0-10), but low titres of antibodies to thyroid tissue were present (colloid 1140, cytoplasm 1180).
She was commenced on D-penicillamine, and discharged after 12 weeks. During a hospital admission for recurrence of knee pain and swelling in December 1983, full blood picture and thyroid function tests remained normal but titres of antibodies to thyroid tissue were greatly increased (microsomal HA 11102,400, IFL 1180). D-penicillamine was increased to 500 mg daily.
Further hospital admission was required in July 1984 following a one month history of lethargy and shortness of breath on exercise. On examination she was grossly anaemic with puffy, swollen cheeks and gum hyperplasia.
Full blood picture demonstrated a haemoglobin concentration of 4.3 gldl with normal indices, a white cell Count of 6.7x10 91l and a platelet count of 650x10 91l. Thyroid function tests revealed free T4 levels of 2.2 pmolll (normal range 9-26) and thyroid stimulating hormone 50 mUll (normal 0.5). Primary hypothyroidism was confirmed by a thryotrophin releasing hormone (TRH) test. D-penicillamine therapy was withdrawn. Gum and rectal biopsies failed to confirm amyloid. Bone marrow studies demonstrated grossly diminished erythropoiesis with dyserythroplastic features.
The patient was transfused and commenced on thyroxine therapy at a dose of 100 p.g in the morning.
Her haemoglobin concentration rose to 8.9 gldl post transfusion and, after four weeks of thyroxine therapy it had risen to 10.1 gldl and she became clinically and biochemically euthyroid (see Figure 1 ). After eight weeks she remained euthyroid on thyroxine 125 p.g in the morning with a haemoglobin concentration of 11.6 g/d!.
Subsequent rechallenge with D-penicillamine failed to reproduce the profound anaemia.
Discussion
Hypothyroidism is a known cause of macrocytic non. megaloblastic anaemia' although the mechanism is not clear.
D-penicillamine, has not previously been reported to cause red cell aplasia or dyserythropoiesis. Chronic forms of red cell aplasia are associated with disturbances of the immune system, including autoimmune hypothyroidismand thymoma.
An association between rheumatoid arthritis and red cell aplasia has been reported and the authors emphasized the role of drugs" and the chronicity of the disorder" in the aetiology of the aplasia.
We believe this is the first report of rheumatoid arthritis and profound anaemia which cannot clearly be attributed to drugs. Furthermore, the close link between remission of anaemia in response to thyroxine, strongly suggests that thyroid deficiency was primarily important in triggering the profound anaemia, especially as subsequent rechallenge with D-penicillamine failed to precipitate a relapse.
